BAJARD ÉP.ESNER, Lola Murielle, Lisa Emily MELYMUK a Luděk BLÁHA. Prioritization of hazards of novel flame retardants using the mechanistic toxicology information from ToxCast and Adverse Outcome Pathways. Environmental Sciences Europe. HEIDELBERG, GERMANY: Springer-Verlag, GmbH, Environmental Sciences Europe, 2019, roč. 31, February, s. 1-19. ISSN 2190-4715. Dostupné z: https://dx.doi.org/10.1186/s12302-019-0195-z.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Prioritization of hazards of novel flame retardants using the mechanistic toxicology information from ToxCast and Adverse Outcome Pathways
Autoři BAJARD ÉP.ESNER, Lola Murielle (250 Francie, domácí), Lisa Emily MELYMUK (124 Kanada, domácí) a Luděk BLÁHA (203 Česká republika, garant, domácí).
Vydání Environmental Sciences Europe, HEIDELBERG, GERMANY, Springer-Verlag, GmbH, Environmental Sciences Europe, 2019, 2190-4715.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10511 Environmental sciences
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW Full Text
Impakt faktor Impact factor: 5.394
Kód RIV RIV/00216224:14310/19:00110362
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.1186/s12302-019-0195-z
UT WoS 000459786300001
Klíčová slova anglicky Flame retardants; ToxCast; AOP; Prioritization; Hazard; Mechanisms of toxicity
Štítky rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: RNDr. Kateřina Nováková, Ph.D., učo 64015. Změněno: 27. 5. 2020 09:09.
Anotace
BackgroundFlame retardants (FRs) are used in most consumer products and textiles to comply with current flammability standards. After the restriction of polybrominated diphenyl ethers, a large number of chemically diverse replacement FRs are increasingly used, but the risk they represent is not yet properly evaluated and their toxicity pathways are still poorly understood.ApproachWe collected in vivo toxicological information on 62 (including 52 non-regulated) FRs and established five prioritization categories (Cat I to V) based on data availability and toxicological concern. We then considered available in vitro toxicological data from ToxCast, as a complement to in vivo information. By combining these information sources, we then explored relevant toxicity mechanisms for nine selected FRs (Cat I) using the AOP (Adverse Outcome Pathway) framework.ResultsFor 20 FRs (Cat V), toxicological data on mammals were absent. Data available were scarce for another 22 FRs, of which 14 FRs (Cat II) may be of toxicological concern. We found substantial information for only ten replacement FRs, of which nine (Cat I) present some toxicological concern: tris-2-chloroethyl phosphate (TCEP), tris(1,3-dichloropropyl)phosphate (TDCIPP), triphenyl phosphate (TPhP), tricresyl phosphate (TMPP), tetrabromobisphenol A (TBBPA), tri-n-butyl phosphate (TNBP), tri(2-butoxyethyl) phosphate (TBOEP), tris(1-chloro-2-propyl) phosphate (TCIPP), 2-ethylhexyl diphenyl phosphate (EHDPP). ToxCast results confirmed in vivo based categorization for several FRs and identified potential molecular targets. For the nine Cat I FRs, we identified several molecular targets, health outcomes and some potential AOPs. However, the complete toxicity pathways leading from molecular targets to adverse health outcomes are still unknown, with the exception of TBBPA-induced neurotoxicity.ConclusionsThe approach presented in this study was particularly useful for the categorization of a large group of replacement FRs with relatively low data availability. We highlight priority compounds that critically need more toxicological studies or FRs for which regulatory measures could be envisaged. Our research also suggests that high toxicity indicated by ToxCast is particularly relevant for predicting higher hazard in vivo. Finally, we indicate several gaps and directions for future research, such as molecular targets that could be tested in vitro and health outcomes for cohort studies.
Návaznosti
EF16_013/0001761, projekt VaVNázev: RECETOX RI
LM2015051, projekt VaVNázev: Centrum pro výzkum toxických látek v prostředí (Akronym: RECETOX RI)
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Výzkumná infrastruktura RECETOX
733032, interní kód MUNázev: European Human Biomonitoring Initiative (Akronym: HBM4EU)
Investor: Evropská unie, European Human Biomonitoring Initiative, Health, demographic change and wellbeing (Societal Challenges)
VytisknoutZobrazeno: 24. 7. 2024 07:36